Why is Hemo Organic falling/rising?

As of 11-Jul, Hemo Organic Ltd's stock price is currently at 9.54, showing no change (0.00%) from the previous trading session. The stock has experienced a significant decline over various periods, with a 1-week return of -5.54% and a 1-month return of -13.43%. Additionally, it has consistently underperformed against the benchmark, with a year-to-date return of -23.43% compared to the Sensex's gain of 5.58%. Today's price summary indicates that Hemo Organic is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. However, there has been a rise in investor participation, with a 23.86% increase in delivery volume on July 10. Despite some positive quarterly results, the company faces significant challenges, including a negative book value, high debt levels, and a weak long-term growth outlook, which contribute to its classification as a strong sell.
In the broader market context, Hemo Organic's short-term performance has been notably poor compared to the benchmark, as evidenced by its 1-week and 1-month returns that are significantly lower than the Sensex's respective declines of -1.12% and -0.02%. This underperformance is compounded by the company's negative EBITDA and high debt-to-equity ratio, indicating financial instability. While the stock's recent price movement has shown some stability with no change today, the overall trend suggests a lack of confidence among investors, particularly given the company's historical underperformance over the last three years.